iOMEDICO AG

Industry / private company


Location: Freiburg, Germany (DE) DE

ISNI: -

ROR: https://ror.org/03j5af397

Show on Map:

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Treatment reality and outcome data of patients with advanced papillary renal cell carcinoma: Data from the German prospective RCC-Registry (2017) Staehler M, Mueller L, Goebell P, Overkamp F, Frank M, Kruggel L, Jaenicke M, Marschner N Conference contribution Treatment reality and outcome data of patients with advanced papillary renal cell carcinoma - data from the German prospective RCC-Registry (2017) Staehler M, Goebell P, Mueller L, Overkamp F, Frank M, Kruggel L, Jaenicke M, Marschner N Conference contribution Interim results from PAZOREAL: A non-interventional study to assess effectiveness and safety of pazopanib and everolimus in the changing mRCC treatment landscape (2017) Bedke J, Welslau M, Boegemann M, Schostak M, Hering-Schubert C, Petzoldt A, Wolf T, et al. Conference contribution A Cross-Sectional Investigation of Fatigue, Mucositis, Hand-Foot Syndrome and Dysgeusia in Advanced Renal Cell Carcinoma Treatment: Final Results From the FAMOUS Study (2016) Goebell P, Mueller L, Hurtz HJ, Koska M, Busies S, Marschner N Journal article SWITCH: A Randomised, Sequential, Open-label Study to Evaluate the Efficacy and Safety of Sorafenib-sunitinib Versus Sunitinib-sorafenib in the Treatment of Metastatic Renal Cell Cancer (2015) Eichelberg C, Vervenne WL, De Santis M, Von Weikersthal LF, Goebell P, Lerchenmueller C, Zimmermann U, et al. Journal article A cross-sectional investigation of fatigue in advanced renal cell carcinoma treatment: results from the FAMOUS study (2014) Goebell P, Muench A, Mueller L, Hurtz HJ, Koska M, Busies S, Marschner N Journal article
‹ 1 2 3 ›